Israeli researchers have developed a simple and cheap blood test that was found to provide early detection for many types of cancer in clinical trials.
The promising new blood test, developed by scientists at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beersheva, can detect minuscule changes in the blood of a person with a cancerous growth somewhere in the body, even before the disease has spread.
In a clinical trial involving 200 patients and a control group, the test identified specific common cancers such as lung and ovarian cancer in 90 percent of the patients and found other types of cancer, as well.
“This is still research in the early stages of clinical trials,” said Kapelushnik, who is also head of the department of pediatric hemato-oncology at Soroka hospital.
“But the purpose is to develop an efficient, cheap and simple method to detect as many types of cancers as possible. We want to be able to detect cancer while a patient is still feeling good, before it has a chance to metastasize, meaning fewer treatments, less suffering and many more lives saved.”
More clinical trials will be conducted in the next 18 months.
Does the cliche game-changer apply?